ALEXIS N LACRUE
Medical Practice at Skylake Pl, Tampa, FL
License number
Florida 48155
Issued Date
Jun 1, 2016
Effective Date
Jun 1, 2016
Expiration Date
Aug 31, 2018
Category
Health Care
Type
Clinical Laboratory Personnel
Address
Address
11907 Skylake Pl APT D, Tampa, FL 33617
Phone
(813) 849-3292
Professional information
Research Associate At University Of South Florida
Position:
Adjunct Faculty at University of South Florida, Research Associate at University of South Florida
Location:
Tampa/St. Petersburg, Florida Area
Industry:
Higher Education
Work:
University of South Florida
- United States since Jan 2013
-
Adjunct Faculty
University of South Florida
since Mar 2011
-
Research Associate
University of South Florida
- United States Mar 2008 - Mar 2011
-
Postdoctoral Fellow
Unversity of Missouri-Columbia
Aug 2003 - Jun 2007
-
Doctoral Fellow
University of Missouri-Columbia
Aug 2000 - Jun 2003
-
Masters student
Education:
University of Missouri-Columbia 2003 - 2007
Doctor of Philosophy (Ph.D.), Veterinary Pathology and Pathobiology University of Missouri-Columbia 2000 - 2003
Master of Science (MS), Veterinary Pathobiology New Mexico State University 1995 - 2000
Bachelor's of Science, Animal Sciences New Mexico State University 1995 - 2000
Bachelor of Arts (BA), Biology, General New Mexico State University 1995 - 2000
Minor, Human Biology
Doctor of Philosophy (Ph.D.), Veterinary Pathology and Pathobiology University of Missouri-Columbia 2000 - 2003
Master of Science (MS), Veterinary Pathobiology New Mexico State University 1995 - 2000
Bachelor's of Science, Animal Sciences New Mexico State University 1995 - 2000
Bachelor of Arts (BA), Biology, General New Mexico State University 1995 - 2000
Minor, Human Biology
Skills:
Higher Education, University Teaching, Microscopy, Molecular Biology, Research, Statistics, Teaching, Science, PCR, Lifesciences, Grant Writing, Student Affairs, Qualitative Research, Western Blotting
Languages:
English
Alexis Lacrue
Specialties:
Public Health
Work:
University of South Florida
4(1H)-Quinolones Having Antimalarial Activity With Reduced Chemical Resistance
US Patent:
2013012, May 16, 2013
Filed:
Oct 26, 2012
Appl. No.:
13/661300
Inventors:
Roman Manetsch - Tampa FL, US
Richard Matthew Cross - Brandon FL, US
Dennis Edward Kyle - Lithia FL, US
Tina Susanna Mutka - Tampa FL, US
Alexis Nichole LaCrue - Temple Terrace FL, US
Jordany Richarlson Maignan - Tampa FL, US
Fabian Ernesto Saenz - Quito, EC
Richard Matthew Cross - Brandon FL, US
Dennis Edward Kyle - Lithia FL, US
Tina Susanna Mutka - Tampa FL, US
Alexis Nichole LaCrue - Temple Terrace FL, US
Jordany Richarlson Maignan - Tampa FL, US
Fabian Ernesto Saenz - Quito, EC
International Classification:
C07D 215/233, C07D 413/04, C07D 401/04, C07D 215/56
US Classification:
5142352, 514312, 546156, 546153, 544128, 544363, 51425307
Abstract:
Provided are 4(1H)-quinolone derivatives effective in inhibiting or eliminating the viability of at least one of the stages in the life-cycle of the malarial parasite, and to show a reduced propensity to induce resistance to the compound by the target parasite. In particular, the compounds can be derivatives of phenoxyethoxy-quinolones, and including, but not only, 7-(2-phenoxyethoxy)quinolin derivatives. These compounds may be administered by themselves, with at least one other derivative compound, or with other antimalarial compounds, to an animal or human subject. The therapeutic compositions can be and formulated to reduce the extent of a infection in the recipient subject, or to reduce the likelihood of the onset or establishment of a infection if administered prior to the parasite contacting the subject. The therapeutic compositions can be formulated to provide an effective single dose amount of an antimalarial compound or multiple doses for administering over a period of time.